Express News | Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas With Met Fusion Gene

ReutersApr 25 08:30 ET

Express News | Apollomics Inc Files For Mixed Shelf Of Up To $200M

Moomoo 24/7Apr 1 16:34 ET

12 Health Care Stocks Moving In Monday's After-Market Session

GainersOpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. The market value of their outstanding shares is at $7.4 million. Galecto (NASDAQ:GLTO) shares in

BenzingaApr 1 16:31 ET

Apollomics Price Target Cut to $6.50/Share From $11.00 by EF Hutton

Apollomics Price Target Cut to $6.50/Share From $11.00 by EF Hutton

Dow JonesApr 1 08:48 ET

Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)

TipRanksApr 1 06:30 ET

Apollomics Is Maintained at Buy by HC Wainwright & Co.

Apollomics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 1 06:28 ET